Prospective multicentre open-label randomised controlled trial of 3-month versus 12-month dual antiplatelet therapy after implantation of the new generation biodegradable polymer sirolimus TARGET-eluting coronary stent: protocol of the TARGET DAPT trial

INTRODUCTION: Dual antiplatelet therapy (DAPT) with aspirin and thienopyridine is required after placement of coronary stents to prevent thrombotic complications. However, current recommendation for duration of DAPT remains controversial. Firehawk is a biodegradable polymer applied to recessed ablum...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hongbo, Zhang, Feng, Yang, Ji'e, Zheng, Ming, Cao, Ruifen, Dai, Yuxiang, Li, Chenguang, Yao, Kang, Qian, Juying, Ge, Junbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937074/
https://www.ncbi.nlm.nih.gov/pubmed/31852711
http://dx.doi.org/10.1136/bmjopen-2019-033774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937074/
https://www.ncbi.nlm.nih.gov/pubmed/31852711
http://dx.doi.org/10.1136/bmjopen-2019-033774

Ejemplares similares